Literature DB >> 25981591

CDH1 germ-line missense mutation identified by multigene sequencing in a family with no history of diffuse gastric cancer.

Tirzah Braz Petta Lajus1, Roberto Magnus Duarte Sales2.   

Abstract

Germ-line mutation in CDH1 gene is associated with high risk for Hereditary Diffuse Gastric Cancer (HDGC) and Infiltrative Lobular Carcinoma (ILC). Although somatic CDH1 mutations were also detected in ILC with a frequency ranging from 10 to 56%, CDH1 alterations in more frequent infiltrative ductal carcinoma (IDC) appear to be rare, and no association with germ-line CDH1 mutation and IDC has been established. Here we report the case of a woman diagnosed with IDC at 39years of age, presenting extensive familial history of cancer at multiple sites with early-age onset and with no case of HDGC. Deep sequencing have revealed CDH1 missense mutation c.1849G>A (p.Ala617Thr) in heterozygous and four BRCA2 single nucleotide polymorphism in homozygosis. In this family, the mutation c.1849G>A in the CDH1 gene is not related to HDGC nor ILC. Therefore, here we highlight that multigene analysis is important to detect germ-line mutations and genetic variants in patients with cancers at multiple sites in the family, even if inconclusive genetic counseling can be offered, since hereafter, medical awareness will be held.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CDH1; Germ-line mutation; Infiltrative ductal carcinoma; Molecular diagnosis; Multiplex genetic testing; Next generation sequencing

Mesh:

Substances:

Year:  2015        PMID: 25981591     DOI: 10.1016/j.gene.2015.05.035

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

Review 1.  Next generation sequencing-based emerging trends in molecular biology of gastric cancer.

Authors:  Renu Verma; Prakash C Sharma
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

2.  Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.

Authors:  Peiying Tian; Chunli Liang
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

Review 3.  Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity.

Authors:  Shamshul Ansari; Boldbaatar Gantuya; Vo Phuoc Tuan; Yoshio Yamaoka
Journal:  Int J Mol Sci       Date:  2018-08-16       Impact factor: 5.923

4.  Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.

Authors:  Simone da Costa E Silva Carvalho; Nathalia Moreno Cury; Danielle Barbosa Brotto; Luiza Ferreira de Araujo; Reginaldo Cruz Alves Rosa; Lorena Alves Texeira; Jessica Rodrigues Plaça; Adriana Aparecida Marques; Kamila Chagas Peronni; Patricia de Cássia Ruy; Greice Andreotti Molfetta; Julio Cesar Moriguti; Dirce Maria Carraro; Edenir Inêz Palmero; Patricia Ashton-Prolla; Victor Evangelista de Faria Ferraz; Wilson Araujo Silva
Journal:  BMC Med Genomics       Date:  2020-02-10       Impact factor: 3.063

Review 5.  Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches.

Authors:  Lidia-Sabina Cosma; Sophie Schlosser; Hauke C Tews; Martina Müller; Arne Kandulski
Journal:  Int J Mol Sci       Date:  2022-07-15       Impact factor: 6.208

6.  Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.

Authors:  Julie M Huynh; Christina M Laukaitis
Journal:  Mol Genet Genomic Med       Date:  2016-01-13       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.